Drug Profile


Alternative Names: Luteolin 5-rutinoside

Latest Information Update: 05 Jul 2001

$50 / €47 *
* $ price applies to USA, Canada and Latin America. € price applies to the rest of the world. Final gross prices may vary according to local VAT.

At a glance

  • Originator Funakoshi
  • Class Anti-inflammatories; Antineoplastics; Flavonoids
  • Mechanism of Action Undefined mechanism
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • No development reported Cancer
  • Discontinued Diabetes mellitus

Most Recent Events

  • 05 Jul 2001 Discontinued-Preclinical for Diabetes mellitus in Spain (Unknown route)
  • 03 Aug 1998 No-Development-Reported for Diabetes mellitus in Spain (Unknown route)
  • 29 Jul 1998 No-Development-Reported for Cancer in Japan (Unknown route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top